MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea · Delayed Price · Currency is KRW 1,190.00
-10.00 (-0.83%)
At close: Nov 12, 2026
MEDIZEN HUMANCARE Market Cap
MEDIZEN HUMANCARE has a market cap or net worth of 2.74 billion as of November 13, 2026. It is the 47,837th most valuable company in the world and the 2,736th biggest in South Korea. Its market cap has decreased by 20.67% in one year.
Market Cap
2.74B
Enterprise Value
n/a
Revenue
583.88M
Global Rank
Country Rank
#2,736 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, MEDIZEN HUMANCARE's market cap has decreased from 20.81B to 2.74B, a decrease of -86.82%. That is a compound annual growth rate of -19.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 2.74B | -30.00% |
| Dec 30, 2025 | 3.92B | -46.03% |
| Dec 30, 2024 | 7.26B | -21.25% |
| Dec 28, 2023 | 9.22B | -33.88% |
| Dec 29, 2022 | 13.94B | -13.57% |
| Dec 30, 2021 | 16.13B | -15.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 334.06B |
| DreamCIS | 98.89B |
| HLB bioStep | 75.19B |
| P&K Skin Research Center | 52.56B |
| Kolmar BioTech | 30.76B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 26.14B |
| C&R Research | 22.94B |